BR112013014307A2 - compounds that influence the uptake and metabolism of fatty acids and the production of inflammatory agents and their isolation from cocoa products - Google Patents

compounds that influence the uptake and metabolism of fatty acids and the production of inflammatory agents and their isolation from cocoa products

Info

Publication number
BR112013014307A2
BR112013014307A2 BR112013014307A BR112013014307A BR112013014307A2 BR 112013014307 A2 BR112013014307 A2 BR 112013014307A2 BR 112013014307 A BR112013014307 A BR 112013014307A BR 112013014307 A BR112013014307 A BR 112013014307A BR 112013014307 A2 BR112013014307 A2 BR 112013014307A2
Authority
BR
Brazil
Prior art keywords
uptake
metabolism
isolation
compounds
influence
Prior art date
Application number
BR112013014307A
Other languages
Portuguese (pt)
Inventor
David A Stuart
Joshua D Lambert
W Jeffrey Hurst
Yeyi Gu
Original Assignee
Hershey Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hershey Co filed Critical Hershey Co
Publication of BR112013014307A2 publication Critical patent/BR112013014307A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112013014307A 2010-12-07 2011-12-07 compounds that influence the uptake and metabolism of fatty acids and the production of inflammatory agents and their isolation from cocoa products BR112013014307A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42070110P 2010-12-07 2010-12-07
PCT/US2011/063806 WO2012078797A1 (en) 2010-12-07 2011-12-07 Compounds influencing fatty acid uptake and metabolism and the production of inflammatory agents and methods of isolating them from cocoa products

Publications (1)

Publication Number Publication Date
BR112013014307A2 true BR112013014307A2 (en) 2016-08-02

Family

ID=46207504

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013014307A BR112013014307A2 (en) 2010-12-07 2011-12-07 compounds that influence the uptake and metabolism of fatty acids and the production of inflammatory agents and their isolation from cocoa products

Country Status (5)

Country Link
CN (1) CN103338636A (en)
BR (1) BR112013014307A2 (en)
CA (1) CA2820883A1 (en)
MX (1) MX2013006503A (en)
WO (1) WO2012078797A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104974116B (en) * 2014-04-01 2017-12-01 中国科学院昆明植物研究所 Vibralactone amide derivatives and preparation method and application
CN104974117B (en) * 2014-04-01 2017-12-01 中国科学院昆明植物研究所 Vibralactone secondary alcohol acid ester derivant and its pharmaceutical composition and its application
CN104974118B (en) * 2014-04-01 2017-06-20 中国科学院昆明植物研究所 Vibralactone primary alcohol acid ester derivant and its pharmaceutical composition and its preparation method and application
EP3843762B1 (en) * 2018-08-31 2023-09-20 Innophos, LLC Anti-inflammatory botanical extract of anacardium occidentale

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2049482A1 (en) * 1990-08-24 1992-02-25 Ruth M. Kramer Human cytosolic phospholipase a2
US6297273B1 (en) * 1996-04-02 2001-10-02 Mars, Inc. Use of cocoa solids having high cocoa polyphenol content in tabletting compositions and capsule filling compositions
EP1015006A4 (en) * 1996-04-02 2003-09-24 Mars Inc Cocoa extract compounds and methods for making and using the same
US20070003640A1 (en) * 2005-06-29 2007-01-04 Hammerstone John F Jr Process for controlling the isomerization of (-)-epicatechin and (+)-catechin in edible products
WO2007053641A2 (en) * 2005-11-01 2007-05-10 Mars, Incorporated A-type procyanidins and inflammation
WO2009114716A2 (en) * 2008-03-13 2009-09-17 The Regents Of The University Of California Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling

Also Published As

Publication number Publication date
CN103338636A (en) 2013-10-02
MX2013006503A (en) 2015-05-26
WO2012078797A1 (en) 2012-06-14
CA2820883A1 (en) 2012-06-14

Similar Documents

Publication Publication Date Title
IL249821A0 (en) Omega-3 fatty acid ester compositions
EP2846779A4 (en) Compositions of statins and omega-3 fatty acids
ZA201308469B (en) Nutritional compositions including branched chain fatty acids and methods of using same
HK1205096A1 (en) Method for the preparation of triglycerides of medium-chain length fatty acids
IL231512A0 (en) Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease
SG11201604775TA (en) Composition comprising esters of lignin and oil or fatty acids
HK1206596A1 (en) Pharmaceutical compositions comprising fatty acid esters
ZA201309205B (en) Composition useful for the treatment of lipid metabolism disorders
BR112013024959A2 (en) sn-1 (3) monoacylglycerides and lipid absorption
DK2833740T3 (en) Compositions comprising omega-3 fatty acids and vitamin D for acne vulgaris and / or eczema and methods and uses thereof
EP2809317A4 (en) Fatty acids as anti-inflammatory agents
CL2013001475A1 (en) Process of treating plant products before or after harvest with phosphonic acid and an essential oil; composition comprising phosphonic acid and essential oil.
BR112013012079A2 (en) '' Mass products comprising ethylcellulose and exhibiting reduced oil migration ''
HUE037396T2 (en) Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines
BR112013014307A2 (en) compounds that influence the uptake and metabolism of fatty acids and the production of inflammatory agents and their isolation from cocoa products
EP2726086A4 (en) Compositions containing nitro fatty acids
IL246254B (en) Compositions of omega 3 fatty acids to treat diseases which involve damage to the nervous system
HK1206771A1 (en) Non-annulated thiophenylamides as inhibitors of fatty acid binding proteini(fabp) 4 and/or 5 (fabp) 4 /5
ZA201209082B (en) Accumulation of omega-7 fatty acids in plant seeds
BRPI1013321A2 (en) Processes for producing a triglyceride product, and use of the saturated fatty acid alkyl ester fraction
FI20075619L (en) Fatty acid and fatty acid ester production
FR2978470B1 (en) BOX OF WAITING BOX
TH1301005844B (en) Process for the self-catalysed esterification of fatty acids.
GB201104653D0 (en) Improvements in the manufacture of fatty acids
FR2982629B1 (en) BOX OF WAITING BOX

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)